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Abstract
Introduction: After antiretroviral therapy (ART) became available, there was a decline in the number of deaths in persons
infected with HIV. Thereafter, there was a decrease in the proportion of deaths attributed to opportunistic infections and an
increase in the proportion of deaths attributed to chronic comorbidities. Herein we extend previous observations from a
nationwide survey on temporal trends in causes of death in HIV-infected patients in Brazil.
Methods: We describe temporal trends in causes of death among adults who had HIV/AIDS listed in the death certificate to
those who did not. All death certificates issued in Brazil from 1999 to 2011 and listed in the national mortality database were
included. Generalized linear mixed-effects logistic models were used to study temporal trends in proportions.
Results: In the HIV-infected population, there was an annual adjusted average increase of 6.0%, 12.0%, 4.0% and 4.1% for
cancer, external causes, cardiovascular diseases (CVD) and diabetes mellitus (DM), respectively, compared to 3.0%, 4.0%,
1.0% and 3.9%, in the non-HIV group. For tuberculosis (TB), there was an adjusted average increase of 0.3%/year and a
decrease of 3.0%/year in the HIV and the non-HIV groups, respectively. Compared to 1999, the odds ratio (OR) for cancer,
external causes, CVD, DM, or TB in the HIV group were, respectively, 2.31, 4.17, 1.76, 2.27 and 1.02, while for the non-HIV
group, the corresponding OR were 1.31, 1.63, 1.14, 1.62 and 0.67. Interactions between year as a continuous or categorical
variable and HIV were significant (p,0.001) for all conditions, except for DM when year was considered as a continuous
variable (p = 0.76).
Conclusions: Non HIV-related co-morbidities continue to increase more rapidly as causes of death among HIV-infected
individuals than in those without HIV infection, highlighting the need for targeting prevention measures and surveillance
for chronic diseases among those patients.
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Introduction
The widespread availability of ART led to an initial abrupt
decrease in mortality in individuals infected with HIV, which
leveled off in most countries after a few years [1–3]. Although
causes of death traditionally associated with HIV/AIDS continue
to play a prominent role, other conditions, including cardiovas-
cular diseases (CVD), diabetes mellitus (DM), and cancer emerged
as frequent causes of death [4–8]. In 1996, Brazil became the first
developing country to provide free and universal access to ART.
We have previously described an increase in causes of death due to
conditions generally not associated with HIV infection in Brazil at
the local, regional, and national levels [1,4,9]. The aim of the
present study was to expand our previous analyses of national
temporal trends in selected non-AIDS-related causes of death and
TB in persons with HIV infection.
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Methods
In Brazil, the death certificate (DC) is a standardized form that
is entered into a national electronic database, which is available
online without personal identifiers (http://tabnet.datasus.gov.br/
tabdata/sim/dados/cid10_indice.htm). Primary, secondary, and
contributing causes of death according to the International
Classification of Diseases 10th revision (ICD-10) codes are
available for all deaths that occurred since 1999.
We compared temporal trends in causes of death for individuals
who had HIV/AIDS listed in any field of the DC (ICD-10 codes
B20-B24, Z21-[HIV group]) and for those who did not have HIV/
AIDS mentioned (non-HIV group). Logistic regression models
were fitted with generalized linear mixed-effects models (GLMM)
equations. Statistical methods are described elsewhere [9]. Briefly,
year of death was treated either as a continuous or categorical
variable in the models. In the former case, linear trends are
reported as the average variation per year, while in the latter odds
ratios (ORs) are used to compare annual changes relative to the
baseline year of 1999. Statistical significance was assessed through
differences in slopes in temporal trends testing the interaction term
between HIV status and year. We conducted five separate analyses
in which the outcomes were defined by the presence or absence in
any field of the DC of non-HIV-related cancers, external causes,
CVD, DM and tuberculosis (Table 1). All analyses were performed
in R for Windows 3.0.2 (http://www.r-project.org), using the
package ‘lme4’ for GLMM estimation.
Results
A total of 12,366,853 deaths were reported among adults 18
years of age or older between 1999 and 2011. Of these, 151,706
(1.23%) had HIV/AIDS reported in any field of the DC. Mean
age at death (annual increment) for the HIV and non-HIV groups
were 41.6 (0.39) years and 66.9 (0.16) years, respectively; the
annual increment during the study period was significantly higher
for the HIV group (p,0.001).
The adjusted average increases for non-HIV related cancers
were 6.0% (95%CI=1.05–1.07; p,0.001) and 3.0%
(95%CI=1.02–1.03; p,0.001) per year in the HIV and non-
HIV groups, respectively. Compared to 1999, the ORs for having
non-HIV related cancers listed on the DC in 2011 were 2.31
(95%CI=1.92–2.77; p,0.001) for the HIV group and 1.31
(95%CI=1.22–1.40; p,0.001) for the non-HIV group (Figure
1A).
For external causes, there were adjusted average increases of
12.0% (95%CI= 1.09–1.15; p,0.001) and 4.0% (95%CI= 1.04–
1.05; p,0.001) per year in the HIV and non-HIV groups,
respectively. In comparison to 1999, the ORs for having external
causes mentioned on the DC in 2011 were 4.17 (95%CI= 2.97–
5.85; p,0.001) and 1.63 (95%CI= 1.53–1.72; p,0.01) for the
HIV and non-HIV groups, respectively (Figure 1B).
The adjusted average increases for CVD were 4.0%
(95%CI=21.03–1.05; p,0.001) and 1.0% (95%CI=21.00–
1.02; p,0.001) per year in the HIV and non-HIV groups,
respectively. Compared to 1999, the ORs for having CVD listed
on the DC in 2011 were 1.76 (95%CI= 1.56–1.98; p,0.001) and
1.14 (95%CI= 1.09–1.20; p,0.001) for the HIV and non-HIV
groups, respectively (Figure 1C).
DM had adjusted annual increases of 4.1% (95%CI= 1.02–
1.06; p,0.001) and 3.9% (95%CI= 1.03–1.04; p,0.001) per year
in the HIV and non-HIV groups, respectively. Compared to 1999,
the ORs for having DM listed on the DC in 2011 were 2.27
(95%CI=1.70–3.02; p,0.001) for the HIV group and 1.62
(95%CI=1.54–1.70; p,0.001) for the non-HIV group (Figure
1D).
In contrast, for TB there was an adjusted average increase of
0.3% (95%CI=1.00–1.01; p= 0.42) per year in the HIV group
and a 3.0% decrease (95%CI= 0.97–0.978; p,0.001) for the non-
HIV group. Compared to 1999, the ORs for having TB listed on
the DC in 2011 were 1.02 (95%CI= 0.93–1.12; p= 0.66) and 0.67
(95%CI=0.62–0.73; p,0.001) per year for the HIV and non-
HIV groups, respectively (Figure 1E).
Interactions between year as a continuous or a categorical
variable and HIV were both significant (p,0.001) for all
conditions except for DM when year was considered as a
continuous variable (p = 0.76).
Discussion
We were among the first to describe the emergence of non-HIV
related conditions as important causes of death in HIV-infected
individuals in a developing country setting [1,4,9]. We now
describe a continuous and significant increase in the proportion of
non-AIDS related conditions as causes of death in HIV-infected
persons from 1999 to 2011. DM, CVD, non-HIV related cancers,
and external causes increased significantly more in the HIV group
than in the non-HIV group. In contrast, there was a sustained
decrease of TB as a cause of death in the non-HIV population,
while remaining virtually unchanged in the HIV group. The latter
is in keeping with reports from developed and developing country
settings, where TB remains an important cause of morbidity and
mortality in HIV-infected individuals [6,10,11].
Changes in patterns of causes of death in HIV infected
individuals are mostly ascribed to the widespread availability of
ART [12–14]. Although effective use of ART is associated with
Table1. Definition of groups of disease and ICD-10 codes used in this study.
Disease/group ICD-10 code Comments
HIV group B20-B24, Z21 Not all codes that mention HIV make sense in this context, so Z11.4 was not included among
other codes.
Non-AIDS-related cancers C00-C97 (except C46 and C80-C89) Excludes Kaposi’s sarcoma, immunoblastic lymphoma, Burkitt’s lymphoma, and primary brain
lymphoma.
External causes S00-Y98 Includes violent causes, accidents, non-fatal trauma, poisoning and drug abuse.
Cardiovascular diseases I00-I99 except I46 Excludes cardiac arrest (not a real cause of death).
Diabetes mellitus E10-E14
Tuberculosis A15-A19
doi:10.1371/journal.pone.0094636.t001
Causes of Death in HIV Individuals in Brazil
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Figure1. Odds ratios and 95% confidence intervals comparing the chance of having the disease listed on the death certificate over
time of Non-HIV related cancers (A), external causes (B), cardiovascular diseases (C), Diabetes Mellitus (D) and Tuberculosis (E);
year as a categorical variable and 1999 as the baseline reference.
doi:10.1371/journal.pone.0094636.g001
Causes of Death in HIV Individuals in Brazil
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decreased incidence of conditions associated with advanced
immune deficiency, a significant number of successfully treated
individuals remain in a pro-inflammatory state, which in turn has
been associated with non-AIDS related conditions, particularly
CVD [15,16].
There are data documenting a global increase of CVD in the
HIV-infected population [1,9,17]. It is assumed that the preva-
lence of CVD is higher among age-matched HIV-infected
individuals as a result of a complex interplay between a higher
frequency of well-established risk factors, HIV-related inflamma-
tory and immunologic changes, and the adverse effects of certain
antiretroviral drugs. Smoking, the most important risk factor for
CVD and lung cancer, is more common in HIV-infected
individuals than in the general population [17] and may explain
our findings at least partially.
As life expectancy increases among people living with HIV/
AIDS, a growing number of individuals are at risk of co-morbid
conditions that typically occur at older ages, including cancers and
DM [5,18,19]. As an example, we have recently reported an
increase in the incidence of both non-HIV and HIV-related
cancers in HIV-infected in Rio de Janeiro, with lung cancer
leading the former group [4]. Given the relatively high prevalence
of co-infections with hepatitis B and C viruses in Brazil [20], one
can expect an increasing importance of hepatic cancers as a cause
of morbidity and mortality as HIV individual live longer. The
significantly faster growth of external causes as causes of death in
the HIV-infected population, which may be partially attributed to
life style [21], is a matter that we believe deserves further
investigation.
In Brazil, as elsewhere, the metabolic syndrome is increasingly
common in HIV infected individuals and may play an important
role in the faster growth of DM and DCV as causes of death in the
HIV infected population in comparison to the general population
[22].
It should be noted that our findings cannot be attributed to
faster aging of the HIV-infected population alone. Even though
the mean age of death in the general population increased less
than the mean age of death in the HIV group (0.24% vs. 0.94%
per year), all the models used were controlled for age. Moreover, it
has been estimated that in Brazil two thirds of the HIV-infected
individuals who died in the post-HAART era were aged 30 to 49
years [23].
A major strength of our study is that we analyzed all DC issued
nationwide for a period spanning over one decade. Another
strength is the use of any mention of conditions on the DC, which
overcomes one of the limitations of the current ICD system, which
does not cover some diseases associated with HIV.
Our study has several limitations, since we analyzed data from
DC, which may lack sensitivity and specificity for certain medical
conditions. Nonetheless, by using a strategy that is commonly
utilized in studies that investigate occupational hazards, we were
able to estimate the odds ratios by comparing individuals who had
HIV/AIDS cited in their DC to those who did not. As is the case
for all population-based studies, particularly those involving only
death certificates data, we cannot rule out the influence of
unmeasured confounders potentially associated with non-HIV
associated causes of death, including smoking habits and hepatitis
B and/or C serostatus. Nonetheless, we have previously reported a
significant underreporting of HIV/AIDS as a cause of death in
individuals known to be HIV-infected in Rio de Janeiro [24].
Predictors of underreporting included male gender, older age, and
higher CD4 counts, all of which are associated with CVD and
DM.
Conclusions
The continuous increase in the frequency of non-AIDS related
causes of death described in the present study might become an
even greater burden for health systems as the HIV-infected
population ages. On the other hand, some of these conditions,
particularly CVD, DM, and lung cancer, can be prevented or
effectively managed by public health interventions, such as
smoking cessation and lipids, glucose, an blood pressure control.
Given the potential role played by unmeasured confounders,
further studies are necessary to address and elucidate the results
present herein. Finally, despite the availability of effective
preventative interventions, TB remains a major cause of death
among HIV-infected patients. Its prevention should be a major
focus of public health interventions, including wider use of
isoniazid primary prophylaxis when indicated.
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